A detailed history of Equita Financial Network, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Equita Financial Network, Inc. holds 823 shares of LLY stock, worth $638,960. This represents 0.27% of its overall portfolio holdings.

Number of Shares
823
Previous 729 12.89%
Holding current value
$638,960
Previous $660,000 10.45%
% of portfolio
0.27%
Previous 0.28%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$772.14 - $960.02 $72,581 - $90,241
94 Added 12.89%
823 $729,000
Q2 2024

Jul 31, 2024

BUY
$724.87 - $909.04 $51,465 - $64,541
71 Added 10.79%
729 $660,000
Q1 2024

May 02, 2024

BUY
$592.2 - $792.28 $21,911 - $29,314
37 Added 5.96%
658 $512,000
Q3 2023

Oct 30, 2023

BUY
$434.7 - $599.3 $269,948 - $372,165
621 New
621 $334,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $738B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Equita Financial Network, Inc. Portfolio

Follow Equita Financial Network, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Equita Financial Network, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Equita Financial Network, Inc. with notifications on news.